Ng Siew C, Kamm Michael A
St. Mark's Hospital, Harrow, United Kingdom.
Am J Gastroenterol. 2008 Apr;103(4):1029-35. doi: 10.1111/j.1572-0241.2008.01795.x. Epub 2008 Mar 26.
Three-quarters of the patients with Crohn's disease (CD) require surgery involving a resection in the course of their disease. Even if all macroscopically involved bowel is removed, the disease usually recurs proximal to, and at, the anastomosis. This often leads to the recurrent need for treatment of active disease, complications, and reoperation. Ileocolonoscopy has an important place in the assessment of postoperative Crohn's recurrence. The limited available data regarding drug therapy in the postoperative setting suggest that optimal management should include identification of high-risk patients earlier and more widespread use of immunosuppressive therapy than was previously recommended, and colonoscopic monitoring. Such strategies to prevent recurrence then need to be prospectively evaluated. This article examines the evidence for medical prophylaxis of postoperative CD, and proposes a treatment strategy based on current evidence.
四分之三的克罗恩病(CD)患者在病程中需要接受包括肠段切除的手术。即便所有肉眼可见受累肠段均被切除,疾病通常仍会在吻合口近端及吻合口处复发。这常常导致反复需要治疗活动性疾病、处理并发症以及再次手术。结肠镜检查在评估克罗恩病术后复发方面具有重要地位。关于术后药物治疗的现有数据有限,提示最佳管理应包括更早识别高危患者、比以往推荐更广泛地使用免疫抑制治疗以及结肠镜监测。然后需要对这类预防复发的策略进行前瞻性评估。本文审视了克罗恩病术后药物预防的证据,并基于当前证据提出了一种治疗策略。